Publication | Open Access
Targeting the MKK7–JNK (Mitogen-Activated Protein Kinase Kinase 7–c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors
28
Citations
26
References
2019
Year
Covalent InhibitorsDrug TargetEffective Covalent InhibitorMolecular PharmacologyMedicinal ChemistrySignaling PathwayReceptor Tyrosine KinaseAnti-cancer AgentCell SignalingNovel TherapyMolecular SignalingPharmacologyCell BiologyDrug TargetingSignal TransductionRational Drug DesignPyrazolopyrimidine ScaffoldProtein Kinase Mkk7MedicineDrug Discovery
The protein kinase MKK7 is linked to neuronal development and the onset of cancer. The field, however, lacks high-quality functional probes that would allow for the dissection of its detailed functions. Against this background, we describe an effective covalent inhibitor of MKK7 based on the pyrazolopyrimidine scaffold.
| Year | Citations | |
|---|---|---|
Page 1
Page 1